There are 10 candidates for 10 available seats in the board council
Jean Pierre Collaveri
Beyond regular participation to congress, world meetings notably, I had the opportunity to contribute in some activities of the association as the jury of the young investigator award, by giving talks during APGI – Setaram workshop or the recent formulation days, or as co-chair of the next APGI-Skin forum symposium (Sept. 2019). As a board council member, I want to continue my implication in the society. Indeed, through my collaborative works with companies, I understood the crucial role of effective interactions between academics and industrials, including raw materials or equipments suppliers. Because of the composition of its board and its activities, APGI is an essential and recognised link for people who are concerned with pharmaceutical technology.
She spent two years as a post-doctoral fellow in the Helmholtz Institute for Pharmaceutical Research (Saarbrücken, Germany), working on the development of innovative nanomedicines using biopolymers in the context of infectious diseases (supervisor: Pr. Claus-Michael Lehr).
Appointed in 2015 as an Associate Professor in MINT laboratory (Translationnal Micro and Nanomedicines), led by Pr. Saulnier (University of Angers, France), she is the leader of a research axe called “Surface functionalization and self-assembly”, in close collaboration with Prof. Passirani. Her main objective is to design fonctionnalized nanocarriers, for the smart delivery of anticancer compounds.
Core research interest
Improving the well-being of people is the main preoccupation of my research and that's why I started a research activity in the sensory science over 20 years ago. First focused on development of topical galenics, I have developed referential and methods adapted to the evaluation of these products. Today, my research field is wider and it integrates the studies of sensation, acceptability and emotion in a quality by design approach of variables formulations. This ensures design of product that meets the expectations of the consumers in terms of performance safety and acceptability.
Patrice Tewa Tagne
Pharmacist, I obtained a master degree in Pharmaceutical Sciences at Paris XI University and my PhD in Pharmacotechnical engineering at Lyon 1 University in 2007. I served also as Intern at Lyon’ Hospitals from 2001 to 2006.
Since 2014, I joined Biocodex as Experimental Drug & Product Development Manager. My main activities deal with pharmaceutical innovation, industrial development, validations (process and analytical methods), transfers, clinical evaluation and regulatory expertise.
Member of the Association of Industrial Galenic Pharmacy (APGI) for many years, I would like to apply again as a candidate to the APGI board. Some years ago, I had the possibility to contribute as the jury of the young investigator award. I wish to continue to promote APGI activities within the industrial field as well as contribute for its development as a scientific society of reference.
Responsable du Master Ingénierie pharmaceutique (M1 + M2 en alternance)
Référent apprentissage du Master IP.
Responsable de la plateforme de pharmacie galénique et de technologie industrielle.
Chargé de mission « Université numérique » auprès de l’UNESS.
Créateur de Pharma3D, monde virtuel de la pharmacie.
Président de l’Association pour la Promotion des Pharmacies EXpérimentales (APPEX)
Responsable du parcours « Pharmacie d’Officine »
Membre élu du Conseil de la Faculté de Pharmacie de Strasbourg
Membre du Conseil scientifique de l’APEPPU – formation post-universitaire.
Conseiller ordinal – Conseil Régional de l’Ordre des Pharmaciens – Région Alsace. Membre de la commission de discipline de l’ordre (Région Alsace).Membre de l’APMSA (Association des pharmaciens maîtres de stage d’Alsace).